HemaClear is used for bloodless orthopedic limb surgery. It is a sterile and cost-effective device that exsanguinates, occludes and provides a clearer surgical field in a single disposable product. The launch also marks HemaClear’s introduction to the German market.
Related Articles on Orthopedic Devices:
Smith & Nephew Voluntarily Withdraws Hip System Component
Maine Plans Statewide Medical Image Archive Pilot
Amedica Names Brian McEntire Chief Technology Officer
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
